|
|
||||||||
Department of Radiology, Division of Nuclear Medicine, Mercy Hospital, Pittsburgh, Pennsylvania
Correspondence: For reprints contact: Elliott H. Turbiner, DO, Div. of Nuclear Medicine, Mercy Hospital, 1400 Locust St., Pittsburgh, PA 15219.
ABSTRACT
A case in which hepatic artery perfusion scintigraphy (HAPS) correctly predicted the outcome of chemotherapy in a patient with metastatic liver disease is presented. In spite of angiography showing "proper" position of the infusaid catheter, HAPS showed preferential perfusion to the right lobe of the liver. Computed tomography pre- and postchemotherapy showed a changing pattern of the metastatic foci correlating with the perfusion demonstrated by HAPS.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |